4
Changes in Ownership
Vericel Corp Filed Acc 0001140361-26-026930
Chief Medical Officer sold 10,000 shares at $45.00 ($450,000)
- Chief Medical Officer acquired 10,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hopper Jonathan Mark Chief Medical Officer | 2026-06-26 | Option exercise 10b5-1 | +5,000 | $29.82 | $149,100 | 80,753 | D |
| Hopper Jonathan Mark Chief Medical Officer | 2026-06-26 | Sale 10b5-1 | −5,000 | $45.00 | $225,000 | 75,753 | D |
| Hopper Jonathan Mark Chief Medical Officer | 2026-06-26 | Option exercise 10b5-1 | +5,000 | $29.82 | $149,100 | 80,753 | D |
| Hopper Jonathan Mark Chief Medical Officer | 2026-06-26 | Sale 10b5-1 | −5,000 | $45.00 | $225,000 | 75,753 | D |
| Derivatives | |||||||
| Hopper Jonathan Mark Chief Medical Officer | 2026-06-26 | Option exercise · Stock Option (Right to Buy) 10b5-1 | +5,000 | 25,000 | D | ||
| Hopper Jonathan Mark Chief Medical Officer | 2026-06-26 | Option exercise · Stock Option (Right to Buy) 10b5-1 | +5,000 | 20,000 | D | ||
| Open-market sales · 10,000 sh · avg $45.00 · $450,000 | |||||||
Loading xslF345X06/form4.xml…